• Oct 08, 2015 | Webcast

    Treatment of Disorders: Bone-Kidney Crosstalk

    Paul Miller, M.D., FACP; Mary Leonard, M.D.; Tamara Isakova, M.D.; Stuart Sprague, D.O.; Seiji Fukumoto, M.D., Ph.D.
    Investigation of Metabolic Bone Diseases, Integrative Physiology of the Skeleton

    Chairs:
    Paul Miller, M.D., FACP, Colorado Center for Bone Research
    Mary Leonard, M.D., Stanford School of Medicine

    Speakers:
    Phosphate Binding in the Control of FGF23
    Tamara Isakova, M.D., Northwestern University

    Renal Osteodystrophy/Treatment
    Stuart Sprague, D.O., Northshore University Health System

    Treatment of FGF23-related Hypophosphatemic Diseases
    Seiji Fukumoto, M.D., Ph.D., University of Tokyo Hospital

    Supported by an educational grant from Fresenius Medical Care North America, Keryx Biopharmaceuticals, Inc., Lilly, Merck & Co., Inc., Ultragenyx Pharmaceutical Inc.

    Length: 60 minutes

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Policies and Procedures for more details